IVS-001 Logo RGB FNL.jpg
iVexSol® Closes $23.8M Series A-3 Financing; Funds to Revolutionize the Production of Lentiviral Vectors
January 26, 2023 08:00 ET | iVexSol Intelligent Vector Solutions
LEXINGTON, Mass., Jan. 26, 2023 (GLOBE NEWSWIRE) -- iVexSol Inc., a technology-based lentiviral vector (LVV) contract development and manufacturing organization (CDMO), announced $23.8 million in...
iVexSol Announces $2M in Seed Funding
September 24, 2019 08:00 ET | iVexSol Intelligent Vector Solutions
BOSTON, Sept. 24, 2019 (GLOBE NEWSWIRE) -- iVexSol, a newly formed viral vector manufacturing company, today announced $2.0 million in new convertible debt funding led by Casdin Capital, LLC and...